ASPENBeiGeneEHAESMONSCLCPD-1Waldenström

BeiGeneius Resources

Search results for all Resources:

BeiGeneius - Lymphoma management during the COVID-19 pandemic: New evidence-based insights and recommendations - Agenda
New
 pdf   07/2021
BeiGeneius - Lymphoma management during the COVID-19 pandemic: New evidence-based insights and recommendations - Agenda
What are the diagnostic considerations and clinical features for patients presenting with Waldenström’s macroglobulinemia symptoms?
New
 video   00:22:21   07/2021
What are the diagnostic considerations and clinical features for patients presenting with Waldenström’s macroglobulinemia symptoms?
What is Waldenström’s macroglobulinemia?
New
 video   00:03:49   07/2021
What is Waldenström’s macroglobulinemia?
Waldenström’s macroglobulinemia cell morphology
New
 video   00:03:33   07/2021
Waldenström’s macroglobulinemia cell morphology
The Waldenström’s macroglobulinemia-specific immunophenotype
New
 video   00:01:13   07/2021
The Waldenström’s macroglobulinemia-specific immunophenotype
The implication of genotypes in Waldenström’s macroglobulinemia
New
 video   00:04:07   07/2021
The implication of genotypes in Waldenström’s macroglobulinemia
Is it Waldenström’s macroglobulinemia, MGUS or IgM myeloma?
New
 video   00:01:25   07/2021
Is it Waldenström’s macroglobulinemia, MGUS or IgM myeloma?
Key diagnostic assessments when considering Waldenström’s macroglobulinemia
New
 video   00:01:27   07/2021
Key diagnostic assessments when considering Waldenström’s macroglobulinemia
Summary
New
 video   00:00:37   07/2021
Summary
Case study Diagnosing Waldenström’s macroglobulinemia: A patient’s journey
New
 video   00:20:36   07/2021
Case study Diagnosing Waldenström’s macroglobulinemia: A patient’s journey
Debate Should all patients undergo mutation analysis of MYD88 and CXCR4 as part of the Waldenström’s macroglobulinemia diagnostic work up?
New
 video   00:16:11   07/2021
Debate Should all patients undergo mutation analysis of MYD88 and CXCR4 as part of the Waldenström’s macroglobulinemia diagnostic work up?
Q&A What challenges do we face in diagnosing Waldenström’s macroglobulinemia?
New
 video   00:17:32   07/2021
Q&A What challenges do we face in diagnosing Waldenström’s macroglobulinemia?
Q&A When you have a high-quality bone marrow aspirate, is a bone marrow biopsy necessary for diagnosis?
New
 video   00:01:35   07/2021
Q&A When you have a high-quality bone marrow aspirate, is a bone marrow biopsy necessary for diagnosis?
Q&A How do you differentiate marginal zone lymphoma with IgM versus Waldenström’s macroglobulinemia?
New
 video   00:02:45   07/2021
Q&A How do you differentiate marginal zone lymphoma with IgM versus Waldenström’s macroglobulinemia?
Q&A Do you test for amyloidosis in the bone marrow biopsies of patients with Waldenström’s macroglobulinemia? Should this be done routinely for Waldenström’s macroglobulinemia patients or only when amyloidosis is suspected clinically?
New
 video   00:02:21   07/2021
Q&A Do you test for amyloidosis in the bone marrow biopsies of patients with Waldenström’s macroglobulinemia? Should this be done routinely for Waldenström’s macroglobulinemia patients or only when amyloidosis is suspected clinically?
What proportion of patients with Waldenström’s macroglobulinemia have neuropathy as their primary symptom? What is your favored treatment choice for neuropathy for patients with Waldenström’s macroglobulinemia?
New
 video   00:02:18   07/2021
What proportion of patients with Waldenström’s macroglobulinemia have neuropathy as their primary symptom? What is your favored treatment choice for neuropathy for patients with Waldenström’s macroglobulinemia?
Q&A How does a TP53 gene mutation affect your treatment strategy for a patient with Waldenström’s macroglobulinemia?
New
    07/2021
Q&A How does a TP53 gene mutation affect your treatment strategy for a patient with Waldenström’s macroglobulinemia?
Q&A What is your favored treatment for medically unfit elderly patients with Waldenström’s macroglobulinemia?
New
 video   00:01:15   07/2021
Q&A What is your favored treatment for medically unfit elderly patients with Waldenström’s macroglobulinemia?
Q&A Would you deny BTK inhibitor therapy to a Waldenström’s macroglobulinemia patient who is wild-type for MYD88 and CXCR4 genes?
New
 video   00:01:10   07/2021
Q&A Would you deny BTK inhibitor therapy to a Waldenström’s macroglobulinemia patient who is wild-type for MYD88 and CXCR4 genes?
Q&A Does Waldenström’s macroglobulinemia exist in association with production of immunoglobulins other than IgM, such as IgG or IgA? How are these patients treated?
New
 video   00:02:03   07/2021
Q&A Does Waldenström’s macroglobulinemia exist in association with production of immunoglobulins other than IgM, such as IgG or IgA? How are these patients treated?
Q&A Do you look at serum free light chain levels if there is amyloid in the bone marrow biopsy?
New
 video   00:01:08   07/2021
Q&A Do you look at serum free light chain levels if there is amyloid in the bone marrow biopsy?
BeiGeneius Steering Committe biographies
New
 pdf   07/2021
BeiGeneius Steering Committe biographies
BeiGeneius webinar Q&A
New
 pdf   07/2021
BeiGeneius webinar Q&A
BeiGeneius Bulletin Issue 2
New
 pdf   07/2021
BeiGeneius Bulletin Issue 2
BeiGeneius Bulletin Issue 3
New
 pdf   07/2021
BeiGeneius Bulletin Issue 3
BeiGeneius webinar #4 Save the Date
New
 pdf   07/2021
BeiGeneius webinar #4 Save the Date
BeiGeneius webinar 4 invitation letter
New
 pdf   07/2021
BeiGeneius webinar 4 invitation letter
BeiGeneius webinar #3 Q&A
New
 pdf   07/2021
BeiGeneius webinar #3 Q&A
BeiGeneius - Challenges in the diagnosis, staging and clinical work-up of Waldenström’s macroglobulinemia: A practical guide to current best practice
 video   01:31:49   11/2020
BeiGeneius - Challenges in the diagnosis, staging and clinical work-up of Waldenström’s macroglobulinemia: A practical guide to current best practice
PD-1 inhibitors for NSCLC: Where are we now?
 lecture   09/2020
PD-1 inhibitors for NSCLC: Where are we now?
PD1 inhibitors on the horizon for NSCLC: Current knowledge, future possibilities
 image   09/2020
PD1 inhibitors on the horizon for NSCLC: Current knowledge, future possibilities
EHA25 - Virtual Satellite Symposium - Flyer
 pdf   05/2020
EHA25 - Virtual Satellite Symposium - Flyer
EHA25 - Virtual Satellite Symposium Agenda
 image   05/2020
EHA25 - Virtual Satellite Symposium Agenda
EHA25 - Virtual Satellite Symposium
 pdf   05/2020
EHA25 - Virtual Satellite Symposium